Pluristem Therapeutics Stock Price (NASDAQ:PSTI)

Add to My Stocks
$1.14 $0.01 (0.88%) PSTI stock closing price Feb 17, 2017 (Closing)
Prev Close* : $1.13
Market Cap:
$109.51M
Day Low: $1.12
52 Week Low: $1.04
Open: $1.14
Volume: 201077
Day High: $1.14
52 Week High: $1.85
Dividend:
N/A

Latest Stock Market News

Latest Articles

Pluristem Therapeutics News - From Partners

Pluristem Announces Bought Deal Offering   by Globe Newswire on Jan 19, 2017

PSTI Stockcharts

View PSTI PE ratio, PS ratio stocks charts and compare with peers.
PSTI Chart
Note: Compare Pluristem Therapeutics stock price history with the index and industry peers.

Pluristem Therapeutics Valuation

PB ratio (
price to book ratio
)
2.45

Pluristem Therapeutics Financial Ratios

Receivables Turnover
2.57

PSTI Industry Peers

Company Price Change (%)
Vivus (VVUS)1.090.01 (0.93%)
Novelion Therap (NVLN)10.780.05 (0.46%)
United Therapeutics (UTHR)168.160.26 (0.15%)
Athersys (ATHX)1.170.01 (0.85%)
Steadymed (STDY)3.20 (0%)
Mesoblast (MESO)6.410.09 (1.42%)
Capricor Therapeutics (CAPR)3.110.05 (1.58%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Peregrine Pharma (PPHM)0.550.11 (24.83%)
Fate Therapeutics (FATE)3.930.54 (15.93%)
Myriad Genetics (MYGN)18.621.35 (7.82%)
Puma Biotech (PBYI)40.252.9 (7.76%)
Clovis Oncology (CLVS)65.84.43 (7.22%)
Agenus (AGEN)4.510.28 (6.62%)
Stemline Therapeutics (STML)6.80.4 (6.25%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017
CompanyPriceChange (%)
Kindred Biosciences (KIN)60.2 (3.23%)
Novavax (NVAX)1.510.05 (3.21%)
Ophthotech (OPHT)4.50.14 (3.02%)
China Biologic Products (CBPO)110.142.93 (2.59%)
NeoGenomics (NEO)7.980.17 (2.09%)
Dynavax Technologies (DVAX)40.08 (1.96%)
MannKind (MNKD)0.5260.01 (1.86%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 21, 2017

Pluristem Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues2.84M0.37M0.37M0.67M0.71M
Net Income-23.24M-24.67M-26.93M-21.15M-14.79M
Total Operating Expense26.06M25.63M28.21M22.87M15.73M
view Pluristem Therapeutics Inc. income statement
balance sheet20162015201420132012
Total Assets45.94M68.15M74.02M68.31M47.42M
Total Liabilities7.78M10.01M11.9M10.85M9.67M
Shareholders Equity38.15M58.14M62.12M57.46M37.74M
view Pluristem Therapeutics Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-0.92M-2.63M-0.59M0.33M6.1M
Net Cash From (Used By) Operating Activities-18.52M-20.6M-19.12M-16.88M-3.27M
Increase (Decrease) In Prop Plant And Equipment-1.72M-0.81M-1.57M-4.3M-1.48M
view Pluristem Therapeutics Inc. cashflow statement

Pluristem Therapeutics Inc. Stock News - Partner Headlines

GuruFocus insider data   on Sep 27, 2015

Pluristem Therapeutics Stock Message Board

Pluristem Therapeutics stock price ended the last trading day at 1.14. Looking at Pluristem Therapeutics market capitalization, which currently stands at 109.51M, we can say that PSTI stock is a Micro cap stock. Pluristem Therapeutics valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Pluristem Therapeutics stock price and Pluristem Therapeutics share price mean the same thing. The volume number in Pluristem Therapeutics stock quote data shows the number of shares traded. For Ex: 201077 Pluristem Therapeutics shares were traded as of last trading day, as seen from Pluristem Therapeutics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. One can observe stock price trends and check for volatility by checking Pluristem Therapeutics stock price history.